Friday 6 November 2026 Export IQV’s income statement to Excel — free account

IQVIA Holdings Inc.

IQV Healthcare Diagnostics & Research

IQVIA Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $16.3 billion, up 5.87% from fiscal 2024.

Revenue: +8.00%
EPS: +10.2%
Free cash flow: −21.3%
Total debt: +7.42%

Quarter to September 2026, against a year earlier

269.78 4.90 +1.85%

Follow IQV

Alert me

Market cap: $43.7B
P/E: 31.8×
Fwd P/E: 34.8×
Dividend yield: —
F-score: 4/9
Altman Z: 2.05
Beneish M: −2.59
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

IQVIA Holdings Inc. (IQV) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, IQVIA Holdings Inc. (IQV) trades at a price to free cash flow of 21.0×. Over the past ten years it has ranged from 11.0× (May 2025) to 47.1× (June 2019); the current reading is higher than 35% of that period. That is below the Diagnostics & Research industry median of 33.5× and in line with the Healthcare sector median of 21.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/IQV/price-to-free-cash-flow" width="100%" height="360" style="border:0" loading="lazy" title="IQVIA Holdings Inc. price to free cash flow, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/IQV/metrics/price-to-free-cash-flow">IQVIA Holdings Inc. (IQV) price to free cash flow — stockrow.com</a></p>

Period	Price to free cash flow	Change
FY2025	18.2×	9.42%
FY2024	16.7×	(41.00%)
FY2023	28.2×	17.07%
FY2022	24.1×	2.79%
FY2021	23.5×	(8.08%)
FY2020	25.5×	(29.31%)
FY2019	36.1×	21.29%
FY2018	29.8×	(17.67%)
FY2017	36.2×	119.37%
FY2016	16.5×	(22.33%)

Period	Price to free cash flow	Change
Sep 2026	21.3×	49.91%
Jun 2026	14.2×	8.39%
Mar 2026	13.1×	(28.08%)
Dec 2025	18.2×	28.88%
43 more quarters	Free account

Against its own ten years

Low 11.0× High 47.1×

Ten-year median 24.3×

Current reading's percentile 35

Company	Price to free cash flow
DGX Quest Diagnostics Incorporated compare	20.3×
IQV IQVIA Holdings Inc.	21.0×
LH Labcorp Holdings Inc. compare	25.4×
ILMN Illumina, Inc. compare	30.4×
A Agilent Technologies, Inc. compare	38.2×
MTD Mettler-Toledo International, Inc. compare	39.1×
IDXX IDEXX Laboratories, Inc. compare	40.6×
WAT Waters Corporation compare	173×
NTRA Natera, Inc. compare	1,004×
Diagnostics & Research industry median	33.5×
Healthcare sector median	21.1×
Market median	14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

IQVIA Holdings Inc. (IQV) Price to free cash flow

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on IQV

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on IQV

Stockrow Weekly